Given the prevalent overexpression of HSP90A and TIP60 in various tumor cells, a therapeutic strategy that jointly targets HSP90A and TIP60, aiming to diminish LAP-TGF-β1 in exosomes, could provide a novel avenue for suppressing tumor metastasis to the lungs. The gene discussed is TGFB1; the disease is neoplasm.